{"doi":"10.7326/m20-4298","title":"Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension","abstract":"Background: Although intensive blood pressure (BP)–lowering treatment reduces risk for cardiovascular disease, there are concerns that it might cause orthostatic hypotension (OH). Purpose: To examine the effects of intensive BP-lowering treatment on OH in hypertensive adults. Data Sources: MEDLINE, EMBASE, and Cochrane CENTRAL from inception through 7 October 2019, without language restrictions. Study Selection: Randomized trials of BP pharmacologic treatment (more intensive BP goal or active agent) that involved more than 500 adults with hypertension or elevated BP and that were 6 months or longer in duration. Trial comparisons were groups assigned to either less intensive BP goals or placebo, and the outcome was measured OH, defined as a decrease of 20 mm Hg or more in systolic BP or 10 mm Hg or more in diastolic BP after changing position from seated to standing. Data Extraction: 2 investigators independently abstracted articles and rated risk of bias. Data Synthesis: 5 trials examined BP treatment goals, and 4 examined active agents versus placebo. Trials examining BP treatment goals included 18 466 participants with 127 882 follow-up visits. Trials were open-label, with minimal heterogeneity of effects across trials. Intensive BP treatment lowered risk for OH (odds ratio, 0.93 [95% CI, 0.86 to 0.99]). Effects did not differ by prerandomization OH (P for interaction = 0.80). In sensitivity analyses that included 4 additional placebo-controlled trials, overall and subgroup findings were unchanged. Limitations: Assessments of OH were done while participants were seated (not supine) and did not include the first minute after standing. Data on falls and syncope were not available. Conclusion: Intensive BP-lowering treatment decreases risk for OH. Orthostatic hypotension, before or in the setting of more intensive BP treatment, should not be viewed as a reason to avoid or de-escalate treatment for hypertension. Primary Funding Source: National Heart, Lung, and Blood Institute, National Institutes of Health. (PROSPERO: CRD42020153753)","journal":"Annals of Internal Medicine","year":2020,"id":56098,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":88,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9549,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":291340,"name":"Jiun‐Ruey Hu","orcid":"0000-0003-1390-508X","position":1,"is_corresponding":false},{"id":291341,"name":"Jennifer Cluett","orcid":"0000-0002-5744-1099","position":2,"is_corresponding":false},{"id":291342,"name":"Anthony Ishak","orcid":"0000-0003-4590-8365","position":3,"is_corresponding":false},{"id":291343,"name":"Carol Mita","orcid":"0000-0003-3059-1369","position":4,"is_corresponding":false},{"id":291344,"name":"Lewis A. Lipsitz","orcid":"0000-0003-2344-1274","position":5,"is_corresponding":false},{"id":277163,"name":"Lawrence J. Appel","orcid":"0000-0002-0673-6823","position":6,"is_corresponding":false},{"id":291345,"name":"Nigel Beckett","orcid":"0000-0002-7736-3817","position":7,"is_corresponding":false},{"id":291346,"name":"Ruth L. Coleman","orcid":"0000-0002-5194-8550","position":8,"is_corresponding":false},{"id":8,"name":"William C. Cushman","orcid":"0000-0001-7162-2972","position":9,"is_corresponding":false},{"id":39760,"name":"Barry R. Davis","orcid":"0000-0002-6943-5673","position":10,"is_corresponding":false},{"id":293412,"name":"Greg Grandits","orcid":null,"position":11,"is_corresponding":false},{"id":71221,"name":"Rury R. Holman","orcid":"0000-0002-1256-874X","position":12,"is_corresponding":false},{"id":291347,"name":"Edgar R. Miller","orcid":"0000-0003-0157-6258","position":13,"is_corresponding":false},{"id":258469,"name":"Ruth Peters","orcid":"0000-0003-0148-3617","position":14,"is_corresponding":false},{"id":39194,"name":"Jan A. Staessen","orcid":"0000-0002-3026-1637","position":15,"is_corresponding":false},{"id":291348,"name":"Addison A. Taylor","orcid":"0000-0003-3788-3137","position":16,"is_corresponding":false},{"id":39235,"name":"Lutgarde Thijs","orcid":"0000-0002-8108-2356","position":17,"is_corresponding":false},{"id":14,"name":"Jackson T. Wright","orcid":"0000-0003-2557-7239","position":18,"is_corresponding":false},{"id":291349,"name":"Kenneth J. Mukamal","orcid":"0000-0001-8450-6970","position":19,"is_corresponding":false},{"id":291339,"name":"Stephen P. Juraschek","orcid":"0000-0003-4168-2696","position":0,"is_corresponding":true}],"reference_count":41,"raw_metadata":null,"created_at":"2026-07-18T21:05:49.581291Z","pmid":"32909814","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}